Hypertriglyceridemia: risks and perspectives.

Area of Science:

• Cardiovascular Medicine
• Metabolic Disorders
• Lipid Metabolism

Background:

• Hypertriglyceridemia is increasingly recognized as a significant risk factor for coronary artery disease (CAD).
• The relationship between plasma triglyceride levels and CAD incidence is complex and influenced by other lipid parameters.
• The interplay between triglycerides, high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol is crucial in assessing cardiovascular risk.

Purpose of the Study:

• To review the evidence linking hypertriglyceridemia with coronary artery disease (CAD).
• To discuss the implications of combined lipid abnormalities on CAD risk.
• To highlight updated recommendations for managing dyslipidemia and CAD risk.

Main Methods:

• Review of existing scientific literature and prospective studies on triglyceride levels and CAD.
• Analysis of multivariate models to assess the independent contribution of triglycerides to CAD risk.
• Consideration of clinical data and consensus conference recommendations.

Main Results:

• Univariate analysis shows a positive correlation between plasma triglyceride levels and CAD incidence.
• Multivariate analysis reveals that the significance of triglycerides is diminished when HDL cholesterol levels are considered.
• Elevated LDL cholesterol and triglycerides combined with low HDL cholesterol significantly increase CAD risk.

Conclusions:

• Hypertriglyceridemia is an important factor in CAD risk assessment, particularly in conjunction with other dyslipidemias.
• Integrating triglyceride and HDL cholesterol levels into risk assessment and treatment strategies is recommended.
• Management of hypertriglyceridemia should encompass lifestyle modifications and control of co-existing risk factors like hypertension and hypercholesterolemia.